Introduction
O f all infectious diseases, HIV infection continues to significantly contribute to morbidity and mortality in the European Union (EU) and neighbouring countries.
1 EU Member States have committed themselves to provide universal access to comprehensive HIV prevention programmes, treatment, care and support services by 2010. 2, 3 Undeniably, diagnosing HIV infected persons is a necessary, however insufficient, element in achieving universal access to treatment, care and support services, as well as for prevention of further transmission. In EU Member States and European Economic Area (EEA)/European Free Trade Association (EFTA) countries, estimates of people living with HIV being unaware of their infection range from 12% to more than 50%. 4 To facilitate diagnosis and access to HIV-related services, there is a need to move away from a sole reliance on client initiated HIV testing, venturing additional methods such as provider-initiated HIV testing. Against this background, the US CDC revised their recommendations for HIV testing for adults, adolescents and pregnant women in health care settings in 2006, proposing that HIV testing should be part of routine clinical care, while preserving patient's right to decline from the systematic HIV testing offer. 5 This call for a routine offer and recommendation of HIV testing in health care settings, including the adoption of the opt-out approach whereby people are tested unless they clearly refuse, has also been integrated in the new WHO and UNAIDS guidelines (2007) on provider-initiated HIV testing and counselling in health facilities. 6 Antiretroviral therapy (ART) has proven to be effective in reducing the progression of HIV disease and clinical studies have indicated that maximum benefit in terms of reduced morbidity and mortality is obtained when HIV infection is diagnosed and treated early. 7, 8 Although there is no common definition for late diagnosis across Europe, 9 research has revealed that a considerable number of individuals unaware of their infection remain undiagnosed until they present in an advanced stage of HIV disease or with an AIDS-related condition. [10] [11] [12] [13] In the UK and Ireland, a review to assess the occurrence of late diagnosis and associated features was performed among participants with newly diagnosed HIV infection. A significant number of missed opportunities for earlier diagnosis of HIV infection were identified, particularly at the time of consultations for clinical symptoms in the preceding 12 months.
14 Another study conducted in the UK revealed that either patients do not access health care when they have typical sero-conversion symptoms, or health care providers, most notably in primary care, do not make the diagnosis when patients present to them with suggestive symptoms. 13 In a survey among newly diagnosed HIV-positive Africans attending HIV treatment centres across London (UK), 50% of participants presented with late stage disease despite high primary and secondary care use prior to HIV diagnosis. 15 Increasing uptake of HIV testing and counselling and decreasing the number of undiagnosed people is identified as a priority area for HIV prevention. 16 To this end, better understanding of the factors that obstruct (early) HIV testing, as experienced by clients (patients) and health care providers, as well as the barriers at institutional or policy level is urgently needed. Against this background, we conducted a systematic literature review on barriers to HIV testing and counselling in Europe.
Methods
Relevant scientific publications were searched using PubMed and ISI Web of Science, two electronic search engines integrating data from several bibliographic databases. The review was accomplished by using broad search terms and the results being checked to eliminate the possibility of relevant items being missed. A free text strategy was applied, utilizing the following terms: (testing OR testing practices OR testing barriers OR late diagnosis OR late presenter) AND (HIV OR AIDS) AND (1997-2008) AND Europe.
To be eligible, articles needed to be published in English between 1997 and 2008 in a peer-reviewed journal, and report on HIV testing barriers in Europe as a primary study endpoint.
Two of the authors independently screened all of the identified study titles. Those not deemed relevant were disregarded and duplicates removed. Based on the above eligibility criteria, both authors assessed the abstracts. For the included abstracts, the full paper was analysed and again checked for eligibility. Disagreements were solved between the two review authors. The reference lists of retrieved articles were hand searched for other key papers.
In order to gather all existing evidence, any empirical study regardless of practice setting, methodology, response rate and other bias was included. Each barrier in a study was extracted and categorized according to the level where the barrier is experienced: institutional/policy, health care provider or client/patient level. Although some barriers are exclusive to a certain level, it is acknowledged that barriers at institutional/ policy level may have an impact at provider and client/patient level. To solve this overlap, barriers at institutional/policy level were defined as structural and contextual factors surrounding HIV testing, whereas barriers at provider and client/patient level were considered to be person driven.
Results
Using the predefined search terms, 1293 potential manuscripts were identified (figure 1). After initial review for relevance and duplication, 257 abstracts remained to be screened for eligibility. Seventy-four articles were retrieved for full text analysis using the same inclusion criteria. Studies for which no full text in English was obtainable were excluded, as well as those based on data from the early 1990's, before therapeutic interventions that improve the clinical outcome of HIV infection had become available. The reference list of the selected articles was checked for other key papers and this resulted in the inclusion of another six papers. In total, 24 articles met the eligibility criteria and were included in the review (table 1) .
The studies included were conducted in the UK (n = 15); the Netherlands (n = 4); Russia (n = 2); Hungary (n = 2); Italy (n = 1); Switzerland (n = 1); the Balkans (n = 1). The majority of studies-14 out of 24-provided information on barriers experienced at clients' or patients' level. Six studies identified barriers at health care provider level revealed by general practitioners (GPs), midwives and key informants working in the field of HIV and African communities in the UK, including clinical doctors, health promotion specialists and volunteers. Barriers at institutional or policy levels were highlighted in seven studies, incorporating the views of public health officials, prison authorities and directors of drug treatment centres (table 2) .
Barriers at client/patient level
At this level, barriers identified were categorized into low-risk perception, fear of HIV disease, fear of disclosure and accessibility of health services.
Low-risk perception
According to a retrospective study of a large ethnically diverse HIV infected clinic population in South London, only 41% of the HIV infected black Africans were administered an HIV test because they perceived to be at high risk, compared to 72% of the HIV infected native population. 17 Key informants working in the field of HIV and African communities felt that HIV awareness within African communities in Britain is high but this does not translate into a perception of individual risk. This was considered a major issue influencing the uptake of HIV services. 18 In a survey among newly diagnosed HIV-positive Africans attending HIV treatment centres across London (UK), nearly 70% of respondents (169/256) declared that before being diagnosed they had not considered the possibility of being HIV positive. This was reflected in the fact that 64% were not expecting a positive result at the time they tested HIV positive. More than half the respondents did not perceive ill health. 15 A questionnaire survey among pregnant women, who did not accept an HIV test in an antenatal clinic in London, showed that the main reason for declining was that they did not consider themselves at risk. However, it was also demonstrated that this belief was based on patchy HIV knowledge and that some women did not have enough information to decide on HIV testing even after having received an information leaflet on HIV in pregnancy. 19 In a large-scale Internet-based survey among Dutch men who have sex with men (MSM), 43% of respondents (n = 1627) stated that they had never taken an HIV test. In this group of test naïve MSM, low-risk perception was considered as an important reason for not taking an HIV test although 56% of them reported risky sexual behaviour. 20 In a survey among MSM in a sexually transmitted infections Articles retrieved for abstract screening N= 257
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Fear of HIV disease
An in-depth exploratory study among MSM in Scotland described the complexity of the decision-making processes related to HIV testing, incorporating psychological and social factors. The uncertainty about the perceived ability to cope with a positive result, leading to fear is highlighted as an important barrier to HIV testing. 23 Another survey among Scottish gay bar visitors showed that the intention to test in those with two or more recent unprotected anal sex partners was attenuated if accompanied by increased fear of a positive test result. 24 The earlier mentioned Internet-based survey among at-risk Dutch MSM indicated that fear of a positive test result and the detrimental consequences for their life and future is the most important obstacle to undertake an HIV test. 20 Fear and not wanting to know or not feeling ready to cope with a positive result were also frequently mentioned reasons for not accepting an HIV test in the cross-sectional survey among MSM in an STI clinic in Amsterdam, 21 as well as in the study among high-risk genitourinary clinic attendees in London. 22 Although the introduction of the opt-out strategy in a large STI clinic in the Netherlands resulted in a sharp increase in the uptake of HIV testing, Heijman et al. 25 demonstrated that a small group at high risk for HIV, especially MSM, continues to decline the test and that fear is the major reason for opting out. This finding is in accordance with a study evaluating 4 years of standard HIV testing in an STI clinic in South Limburg in the Netherlands. 26 In a survey among HIV-positive patients attending an HIV outpatient clinic in south London (UK), two-thirds of the black African respondents (n = 392) reported fear of dying as an important pre-test concern. 27 In the same line, being afraid of the result was identified as a significant factor refraining from earlier testing in the survey among newly diagnosed Africans in London. 15 A survey among sexually active youth in Bosnia and Herzegovina, Former Yugoslav Republic of Macedonia, Serbia and Montenegro demonstrated that 6.9% from the test naive respondents reported having renounced from HIV testing despite feeling the need for it. The most frequently mentioned reason for not having sought an HIV test was fear of the diagnosis. 28 
Fear of disclosure
Worries about disclosure and breaches of confidentiality were also considered as an obstacle for seeking HIV testing. Some African migrants reported to be fearful to present for a test as it carries a possibility of meeting people they know-an indirect form of disclosure-potentially resulting in blame and future discrimination. 15 Black Africans testing for HIV at a London hospital were found to be twice as likely as non-Black UK residents to be worried about future discrimination if they tested positive. 27 This fear of disclosure increases when accessing community-based services offering HIV testing 29 as well as when accessing specialist services located in sexual health clinics. 18, 27 On the other hand, confidentiality concerns seem also to be related to fears that a positive HIV diagnosis might adversely affect the immigration process. 15, 18, 27 In the Balkan survey, fear that confidentiality would be violated was the second most frequently identified barrier to HIV testing among sexually active, untested youth. Respondents were asked about their likelihood to encourage testing in various risk groups, their own feelings of anxiety when discussing the issue of HIV testing. The questionnaire was designed with closed questions and simple linear visual analogue rating scales FGD, focus group discussions; GU, genitourinary medicine clinics; IDU, injecting drug users; KAP, knowledge, attitudes and practices; VCT, voluntary counselling and testing
HIV testing barriers

Accessibility of health services
Data from studies in the UK showed that migrants experience barriers to access health services for HIV testing and care. A survey among HIV-positive patients attending an HIV outpatient clinic in south London (UK) and a survey among Black African communities in London (UK), reported concerns about where to obtain an HIV test and about entitlement to medical care due to immigration status. 27 This finding has been confirmed by key informants working in the field of HIV and African communities in the UK 18 as well as in the survey among newly diagnosed HIV-positive Africans in London. 15 African migrants in the UK are frequently not aware that an HIV test can be obtained at sexual health clinics without the need of referral. Appointment systems within clinics were also viewed as intimidating for people not familiar with the system, or with poor knowledge of English. 18 Uncertainty regarding the location where HIV testing could be obtained was identified as an additional, although less important, barrier to HIV testing among sexually active youth in the Balkans. 28 
Barriers at health care provider level
A multicentre prospective study carried out in 1995-96 in maternity units in London showed that the uptake of the HIV test was higher among women with whom a pre-test discussion about HIV transmission had taken place but that in more than one-fifth of the booking interviews no such discussion was reported. 30 In a randomized controlled trial of pregnant women in Scotland, it was demonstrated that even providing midwives with equal information and clear protocols on how to offer the HIV test, uptake rates differ significantly among midwives, ranging from 15% to 48%. 31 Overall, midwives doubting whether testing was beneficial for all women and whether testing should be promoted achieved lower uptake rates. 32 Based on this, it was concluded that the uptake of an HIV test depends more on the attitude of the individual midwife than the method of offering the test and the time spent on pre-test counselling. 31 A survey among midwives in one antenatal clinic and a number of postnatal wards in a low-prevalence area in the UK showed that all respondents agreed that antenatal HIV testing is important. However, 31 of 70 felt that their training had not adequately prepared them for understanding the challenges of HIV in pregnancy and delivery. 33 A survey among GPs in the UK revealed that raising the issue of HIV testing in primary care was associated with a high level of anxiety. The majority of GPs rather avoided than promoted the issue of HIV testing, even in high-risk patient groups. 34 Key informants in the field of HIV and working with African communities reported that clinicians outside sexual health clinics and antenatal settings were perceived to be failing to address HIV with their patients. As a consequence, they preferred to recommend attendance at a sexual health clinic rather than to offer an HIV test themselves. This failure implies multiple exposures to health services before an HIV test is undertaken and this process of onward referral complicates the pathway into care. 18 In a survey among newly diagnosed HIV-positive Africans attending HIV treatment centres across London (UK), a total of 59% (146/247) of respondents believed they would have tested earlier if someone had told them they were at risk of HIV, and advice from a doctor was the principal reason for having an HIV test for 40% of respondents. Although primary care was extremely well utilized by this group, HIV testing was not broached by the GP for 82.4% (145/176) of Africans who subsequently tested HIV positive. 15 
Barriers at institutional/policy level
The impact of antenatal HIV testing strategies on the uptake of the test has been demonstrated in the UK throughout the 1990s. At the time when most maternity units in the UK provided testing only at the explicit request of the individual woman or for selected groups of women perceived to be at higher risk, detection rates were low resulting in most HIV infected women remaining undiagnosed at delivery. 35 Possible reasons for this include the difficulty of targeting the appropriate high-risk groups, the poor uptake of testing in those groups, as well as the potentially discriminatory nature of a testing strategy on basis of ethnicity or country of origin. In addition, it was shown that the national policy recommending universal testing in high-prevalence areas was not being implemented. The offer of the test was an exception rather than the norm and the uptake was very low with the maternity unit as the strongest predictor. 30 As a consequence, a universal offer policy was rolled out across the UK during the period 2000-03, resulting in significant improvements in uptake of antenatal HIV testing. 36 A review of HIV prevention policies in prisons in Hungary, Switzerland and Italy, 37 indicated that these countries adopted some kind of policy irrespective of the burden of HIV infection in the prison system. However, it was also demonstrated that the World Health Organisation (WHO) guidelines (1993) on HIV/AIDS in prisons 38 were fully implemented in the penitentiary HIV prevention policies in Switzerland while only partially in Hungary and Italy. Although these guidelines were written to provide indications to prison administrators on the most appropriate way to perform HIV testing practices among prisoners, as well as to manage and prevent new infections, the most important factor that hampered implementation was the lack of awareness and knowledge on the content of the guidelines.
A survey among key informants to assess the practice of HIV testing and counselling in Hungarian drug treatment settings revealed that testing and counselling services are not provided consistently, and did not have a guidance document or protocol. Lack of funding, staff and office space, as well as lack of training of the staff were identified as main barriers to offering on-site HIV testing and counselling. 39 Key informants in the field of HIV and working with African communities in the UK noted that political will, advocacy, as well as financial and human resources, are often lacking in order to target African communities in the UK appropriately. 18 Two qualitative studies among commercial sex workers, one in Moscow and another in St. Petersburg (Russia), demonstrated a few barriers at policy level. 40, 41 They describe administrative and legal consequences for performing sex work, including detainment. There is a similar law for anyone suspected of being a drug user. They impact accessing health care, creating hidden populations. In addition, the programme coverage of the existing STI/HIV prevention programmes appears to be limited due to scarcity of financial and human resources.
Discussion
While there is substantial literature on factors associated with higher and lower testing rates, the body of literature addressing barriers that are critical to effective HIV testing is relatively sparse. This finding on the paucity of relevant literature is in accordance with a recent synthesis of literature assessing reasons why physicians do not test for HIV in the USA 42 and a summary of literature on psychosocial barriers to HIV
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European Journal of Public Health testing in high-income countries. 43 Although the number of relevant studies was limited, identified barriers could be extracted and categorized.
It appears that low-risk perception constitutes a barrier to HIV testing among HIV infected individuals. A second barrier is associated with fear and worries. The perception of HIV as a deadly rather than a chronic manageable disease is an important cause of fear. 23 African migrants in the UK often seemed concerned about disclosure and confidentiality that are closely related to issues of stigma, discrimination and the migration process. 18, 44 In addition, this population group experiences barriers to access health care services for HIV: black African migrants in the UK reported concerns about where to obtain an HIV test and about entitlement to medical care due to immigration status. Unfamiliarity with the health care system and the concept of routinely seeking HIV testing is an additional obstructing factor to HIV testing. 18, 27 However, as it has been shown that decisions about testing are complex and contextualized, promoting awareness of risk and educating people about the benefits of HIV testing and potential interventions may help to shift the balance toward a decision to be tested. 17, 18, 20, 27 It may also be beneficial to make people aware of laws that protect HIV-positive persons from discrimination and to tackle, through community involvement, HIV-related stigma. 18, 28 New approaches to the delivery of testing, including the use of rapid tests and providing tests in locations and conditions that are convenient to clients/patients are highlighted as strategies to overcome barriers. 28, 33 The attitude and the perseverance of the individual health care provider with regard to the offer of the HIV test proved to be important when considering uptake of testing. 31, 32 Nevertheless, clinicians, in particular in primary care, seem to be either reluctant to address HIV or are focussing on HIV ineffectively.
In an effort to increase the access to and the uptake of HIVrelated services, some authors support the idea that clinicians should be trained to be more proactive and confident in addressing HIV testing. 15, 34 This proposal is to be contextualized within the world-wide paradigm shift, the so called normalization, whereby HIV/AIDS is treated like other infectious diseases for which early diagnosis is essential for appropriate treatment and prevention, within the requirements of informed consent and confidentiality. 45 There is even a call for changing the views on how directly health care providers should seek to influence patient choices on testing, in the sense that a kind of soft paternalism is a feature of medical practice which may serve the interest of the fearful. 46 A survey on unmet needs in Europe for HIV testing, treatment and care showed that testing strategies in a number of countries are also changing, promoting an expansion of testing. 47 In this view, the reported barriers at institutional and policy level, such as scarcity of financial and human resources, as well as the need for more trained staff will require considerable investment.
The methodology applied has limitations that may influence the findings in that it is not a full review, as we only included peer-reviewed studies, published in English language. In this way, grey literature was excluded from the review and this may have biased the results. Another limitation derives from the sparse literature available. More than half of the retrieved articles concern studies performed in the UK, followed by those in the Netherlands. Although a small number of studies were conducted in Hungary, Italy, Switzerland, the Balkans and Russia, we found no evidence in the remaining European countries. This knowledge gap needs to be addressed.
The majority of studies provided information on barriers experienced at client or patient level. Most of these studies were based on data from cross-sectional surveys among HIVpositive migrant patients or untested or HIV-negative MSM reporting testing behaviour and reasons for not taking up an HIV test. The few studies reporting on barriers at health care provider level relied on the experiences from pregnant women, midwives and GPs, as well as from key informants working with African communities and indicating the missed opportunities to diagnose HIV infection earlier. Apart from the evidence which served as background for the shift in the antenatal HIV testing strategy in the UK, information with regard to barriers at policy level is fragmented, lacking a conceptual framework that offers an insight on what works, where and why.
The results of this review showed that there is a need for additional research on HIV testing barriers addressing, amongst others, the views and experiences from clients/ patients representing several population groups, health professionals and policy makers. In the context of the current debate to make HIV testing more routinely available in health care settings, it will be crucial to assess whether health care providers are willing and adequately equipped to implement and emphasize provider-initiated HIV testing. It also remains to be seen whether people who undergo HIV testing initiated by a health care provider are as prepared as those who actively seek HIV testing, to cope with the HIV testing process and its follow up. Finally, what impact will the scale up of provider-initiated testing have at the level of the organization of HIV-related services? In other words, it is worth to study whether other barriers will appear, meaning that provider-initiated HIV testing may not be as effective as expected to increase the access to and the uptake of HIV prevention, treatment, care and support services.
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